Aligning mRNA Progress With Regulatory Streamlining - Episode 6
The key to advancing mRNA therapeutics lies in developing more efficient and versatile delivery systems that can overcome challenges around stability, targeting, and safety.
This discussion segment centered around the need for improved mRNA delivery systems to advance therapeutics. Experts spoke about the importance of developing efficient and versatile delivery systems, such as LNPs, to target mRNA molecules to specific cell types or tissues. They also highlighted the need for delivery systems that can overcome shelf life or storage conditions, minimize adverse immune responses, and utilize self-amplifying mRNA delivery systems. The consensus was that delivery is the key to unlocking the full potential of mRNA therapeutics.
Discussion Topics